Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2026-01-15 @ 3:13 PM
Study NCT ID:
NCT00072618
Status:
COMPLETED
Last Update Posted:
2011-10-20
First Post:
2003-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-10
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2003-08
Completion Date Type:
ACTUAL
First Submit Date:
2003-11-05
First Submit QC Date:
None
Study First Post Date:
2003-11-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-10-18
Last Update Post Date:
2011-10-20
Last Update Post Date Type:
ESTIMATED